On Sunday night, while the rest of the entertainment world was focused on the MTV Video Music Awards, Kim Kardashian West took to social media for another reason: to belatedly acknowledge the side effects of a controversial morning-sickness drug she endorses.
The posts on Facebook, Instagram, and Twitter carried the hashtag #CorrectiveAd. They followed an Aug. 7 warning from the U.S. Food and Drug Administration to drugmaker Duchesnay saying that Kardashian's original paid endorsement omitted important safety information.
"I guess you saw the attention my last #morningsickness post received," Kardashian wrote as the VMAs, which she attended, were kicking off in Los Angeles. Kardashian's original post included links to websites with disclosures about the risks of the drug, Diclegis, which was approved in 2013 to treat morning sickness for women who don't respond to more conservative measures.
The rest of Kardashian's post was the kind of boilerplate risk information that voice actors speed through in the final seconds of TV drug ads: "Diclegis has not been studied in women with hyperemesis gravidarum," or extreme, persistent vomiting. She also included warnings about interactions with other medications and alcohol, as well as side effects like drowsiness.
Kardashian first praised the medication in July posts, broadcast to her millions of followers, that started with "OMG. Have you heard about this?" The posts have since been removed.
The FDA asked that the misleading drug messages be corrected in the format they were originally posted. Kardashian's timing on that request meant the posts were buried quickly: Her social media streams were soon overtaken by pictures of her at the VMAs with Kanye West, who, by the way, announced he planned to run for president.